What Biopharmax Group does

Biopharmax Group is a privately held, founder-controlled engineering firm that designs and delivers turnkey biopharmaceutical manufacturing facilities for global pharmaceutical, biotechnology, and CDMO clients. Founded around 1978-1979 in Israel, the company operates through four regional entities (Israel HQ in Herzliya, Biopharmax Inc. in the USA, an Asia engineering hub in Pune, India, and Biopharmax BV in Valletta, Malta) and reports 47 years of industry experience alongside a 15+ year India presence. Its core offering is an end-to-end EPCM (Engineering, Procurement, Construction Management) platform organized into six solution modules (URS & Planning, Design & Engineering, Construction & Management, Software & Control, Commissioning & Validation, and Delivery & Warranty), covering the full facility lifecycle from conceptual design through cGMP-compliant handover and post-delivery support.

The company's technical stack spans process engineering, cleanroom design, CIP/SIP, PW/WFI water systems (Biopuremax), HVAC, DCS/SCADA automation (including PCS7), and IQ/OQ/PQ validation under FDA, EMA, EU GMP Annex 1, ICH Q10, and ISO 14644 frameworks. It integrates proprietary single-use technologies (Aran-biotech bags, Single Use Reactor) and the Superfine Micronizer alongside distributed equipment from third-party OEMs (SP-Penntech, BioBase, MoonMed, Matachana, Famos-medical) sold through an online catalog. Biopharmax's customer base includes large pharma and biotech manufacturers (Abbott, Bayer, Johnson & Johnson/Omrix, Merck, P&G, Pall, Teva, Perrigo, Recipharm, Sigma, Taro, Ferring, HTBT) as well as mid-market cell and gene therapy developers and hospital compounding centers, with a recent move into cell & gene therapy facility design, hospital cellular therapy centers, and government/public health projects (e.g., Ben Gurion Airport COVID-19 laboratories). Revenue is generated primarily through multi-year, project-based EPCM contracts supplemented by hardware sales and recurring post-delivery maintenance, revalidation, and technology transfer services; pricing is quote-based and not publicly disclosed.

Name

Biopharmax Group

Legal name

Biopharmax Group LTD

Website

https://biopharmax.com

Company type

Private

Founded year

1979

Operating status

Operating

Headcount range

51–100 employees

Short description

Biopharmax Group is a privately held Israel-based EPCM firm that designs and delivers turnkey cGMP-compliant biopharmaceutical manufacturing facilities, from URS and engineering through validation and post-handover support, for global pharma, biotech, CDMO, and cell & gene therapy clients across four continents.

Ownership category

akta.pro rank

Product category

Biopharmaceutical Facility Engineering Services

NAICS

Medical Equipment and Supplies Manufacturing (3391), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Surgical & Medical Instruments & Apparatus (3841), Laboratory Apparatus & Furniture (3821)

akta.pro primary industry

Bioprocess Facility, Cleanroom & Utility Systems (HVAC, WFI, CIP/SIP, containment) (HLAAAJAJ)

akta.pro secondary industries

Single-Use Systems Assembly & Consumables Manufacturing (Bags/Tubing/Assemblies) (HLAGAGAH), Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers) (HLAGAIAG), GMP Quality, Validation & Regulatory Support (GMP/CSV/Qualification) (HLAGAGAL)

Keywords

• Biopharmaceutical facility engineering
• Turnkey EPCM services
• CGMP facility construction
• Cleanroom design validation
• Pharma equipment distribution

Headquarters

HQ city

Valletta

HQ country

Malta

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Turnkey EPCM Project Services: Multi-disciplinary engineering, procurement, construction management, commissioning, qualification, validation, and post-handover support delivered under long-tail, project-based contracts with global pharma, biotech, and API manufacturers. Each project spans URS through PQ/SOPs/cGMP-compliant handover.
2. Biopharma Equipment & Product Catalog: Distribution and integration of biopharma equipment (vial washers, autoclaves, incubators, biological safety cabinets, ultrasonic cleaners, freeze dryers, lyophilizers, water purification, sterile filling, sterilization, shakers, drying ovens, etc.) sourced from manufacturers such as SP-Penntech, Matachana, Moonmed, BioBase, Famos-medical, and Biopharmax's own technology brands.
3. Post-Delivery Maintenance, Revalidation, and Technology Transfer Services: Recurring post-handover services including preventive maintenance, revalidation, process optimization support, regulatory audit preparation, spare parts management, operator training, and technology transfer between sites.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Core offering

Biopharmax designs, engineers, procures, constructs, automates, commissions and validates turnkey cGMP-compliant biopharmaceutical manufacturing facilities for global pharma, biotech, and API manufacturers, covering the full lifecycle from User Requirement Specifications (URS) through cGMP handover and post-delivery maintenance. In parallel, the company distributes a complementary catalog of laboratory and pharmaceutical equipment (vial washers, autoclaves, biological safety cabinets, incubators, ultrasonic cleaners, freeze dryers, water purification systems) and integrates proprietary branded technologies such as Biopuremax water systems, Aran-biotech single-use bags, the Single Use Reactor, and the Superfine Micronizer.

Product overview

Biopharmax Group offers a unified turnkey EPCM (Engineering, Procurement, Construction Management) services platform for biopharmaceutical manufacturing facilities, organized into six solution modules: URS & Planning, Design & Engineering, Project Construction & Management, Software & Control, Commissioning & Validation, and Delivery & Warranty. These service modules integrate to deliver end-to-end Cleanroom, Process Optimization, and Automation solutions covering FDA/EMA/EMEA/ISO 14644 regulatory standards. In parallel, Biopharmax distributes a complementary Products Catalog of laboratory and pharmaceutical equipment (manufactured by third parties like SP-Penntech, BioBase, MoonMed, Matachana, and Famos-medical) including the RW-250/RW-500/RW-800 vial washers, Biopuremax water systems, Aran-biotech single-use bags, MOON-TMQ.C autoclaves, the Miniclave M30-B, NSF/EN Class II A2 and Class II B2 Biological Safety Cabinets, the BJPX series of CO2/Climate/Shaking/Platelet/Lighting Incubators, and FamoSonic ultrasonic cleaners. Additionally, Biopharmax integrates Single-Use Bioreactor Systems (disposable bag-based bioreactors with integrated sensors) as a core technology option for cell therapy, insulin, mAb, and recombinant protein manufacturing facilities.

Differentiator

Problem solved

Functional benefit

Products and services

• URS & Planning Conceptual design service including User Requirement Specifications (URS), Basis of Design (BOD), Process Flow Diagrams (PFD), layouts, and cost estimation, with compliance to EMEA and FDA regulatory standards. Sold to pharmaceutical, biotech and CDMO manufacturers planning new or expanded cGMP facilities.
• Design & Engineering Complete biopharmaceutical manufacturing facility design including engineering specs, equipment selection, 3D modeling, MTO/BOM, layouts and PI&Ds, delivered by Biopharmax's in-house global engineering and design staff for pharma and biotech manufacturers.
• Project Construction & Management Procurement, construction supervision, safety procedures, site surveys and global procurement through long-term contracts with leading worldwide brands. Sold to enterprise pharma/biotech manufacturers as part of the EPCM delivery package.
• Software & Control Process automation, instrumentation, control system programming and integration (DCS/SCADA, including PCS7) for biopharmaceutical manufacturing facilities, with 21 CFR Part 11 compliant electronic records, timestamping, tamper-proofing and disaster recovery.
• Commissioning & Validation SAT, commissioning, IQ/OQ documentation, PQ/SOPs, cGMP compliance (FDA, EMA, EU GMP Annex 1, ICH Q10, ISO 14644) and final handover for biopharmaceutical manufacturing facilities.
• Delivery & Warranty Post-handover facility delivery, warranty, preventive maintenance, revalidation, process optimization, regulatory audit preparation, spare parts management, operator training, and technology transfer between sites for biopharmaceutical manufacturing facilities.
• Single Use Reactor Proprietary single-use bioreactor technology for biopharmaceutical processing, showcased at CPHI 2021 in New Delhi (24-26 November 2021) and integrated into Biopharmax facility builds for media prep through primary production across mammalian cell culture, insulin, mAb, recombinant proteins, and cell therapy manufacturing.
• Superfine Micronizer Proprietary micronization equipment for pharmaceutical processing applications, showcased at CPHI 2021 in New Delhi (24-26 November 2021) and offered through Biopharmax's biopharma equipment portfolio.
• Biopuremax Pharmaceutical Water System In-house branded Biopuremax purified water (PW) and water-for-injection (WFI) purification and distribution system used in Biopharmax-designed pharma facilities.
• Aran-biotech Single-Use Systems Bags Aran-biotech proprietary single-use bag systems for pharmaceutical and biotech processing applications, distributed by Biopharmax as part of its single-use equipment catalog.

Quantifiable outcome

• 18–36 months typical project duration from URS to validated handover for new biopharma facility
• +4 more outcomes

Named customers23 records

Segments9 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Seven partnerships are on record, tiered minor.

• SP-PenntechminorOEM/ Whitelabel/ Licensing PartnerSP-Penntech is the manufacturer of the vial washers (RW-250, RW-500, RW-800, RW-1150) sold and integrated through the Biopharmax product catalog for pharmaceutical and biotech applications.
• MatachanaminorOEM/ Whitelabel/ Licensing PartnerMatachana is the manufacturer of the Miniclave M30-B steam sterilizer distributed via Biopharmax's product catalog.
• Moonmed (MoonMed)minorOEM/ Whitelabel/ Licensing PartnerMoonmed manufactures the MOON-TMQ.C Series vertical autoclaves and the MO-MOST-T B-class table-top sterilizer line distributed via Biopharmax's product catalog.
• BioBaseminorOEM/ Whitelabel/ Licensing PartnerBioBase manufactures the incubator lines (BJPX CO2, climate, lighting, shaking, constant temperature/humidity, platelet) and biological safety cabinets (Class I BYKG, NSF Class II A2 and B2, EN-certified) distributed via Biopharmax's product catalog.
• Famos-medical (FamoSonic)minorOEM/ Whitelabel/ Licensing PartnerFamos-medical manufactures the FamoSonic benchtop ultrasonic cleaning baths, the FamoSonic Flush ultrasonic cleaner for MIS instruments, and built-in ultrasonic cleaners (AISI 304 stainless steel) distributed via Biopharmax's product catalog.
• Equality (עושים שוויון)minorImplementation/ SI/ Consulting PartnerEquality is Biopharmax's accessibility service partner, providing the website accessibility plugin and serving as the responsible accessibility center for the Biopharmax website. Contact: Tavor Avrahami, phone 1-700-015-107, [email protected].
• Daniel Law Office (משרד עורכי הדין דניאל)minorOthersDaniel Law Office is the legal counsel that drafted Biopharmax's Terms and Conditions (rights reserved to Daniel law office per the document).

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• CRB Group: CRB is a global EPCM firm dedicated to life sciences and advanced manufacturing facilities, including pharma, biotech, and cell/gene therapy plants. It competes head-to-head with Biopharmax for turnkey facility mandates from the same blue-chip sponsor base.
• IPS (Integrated Project Services): IPS specializes in EPCMV services for pharmaceutical and biotech manufacturing, including process design, cGMP compliance, commissioning and qualification. It is one of the closest direct competitors to Biopharmax's turnkey EPCM model.
• Exyte (formerly M+W Group): Exyte is a global high-tech facility construction and engineering firm with a strong life sciences and biopharma practice, delivering turnkey cleanroom and GMP manufacturing plants. Comparable scope, customer profile and technology focus to Biopharmax.
• PM Group: PM Group is an Irish-headquartered international EPCM/project delivery firm specializing in pharma, medtech and food facility design and construction. Comparable turnkey delivery model and pharma/biotech customer base to Biopharmax.
• NNE: NNE is a pharma engineering and consultancy firm (Novo Holdings-owned) that designs and builds pharma manufacturing facilities including aseptic, fill-finish and biologics plants. Directly comparable to Biopharmax's EPCM services for pharma manufacturers.
• Pharmaplan (part of Capgemini Engineering): Pharmaplan is a European pharma-focused EPCM firm specializing in turnkey design and construction of GMP manufacturing facilities. Highly comparable customer base and project scope to Biopharmax, with similar regulatory expertise.

Broad incumbents

• Fluor Corporation: Fluor is a global engineering, procurement, fabrication, construction and maintenance company with a Life Sciences and Advanced Manufacturing practice. It competes with Biopharmax on larger pharma/biotech facility mandates but operates across many industries.
• Jacobs Solutions: Jacobs is a large diversified professional services firm with significant life sciences EPCM capabilities. It is a broader incumbent competitor for enterprise pharma facility programs, especially at the multi-billion-dollar capex tier.
• Worley (WorleyParsons): Worley is a global engineering and project delivery firm with energy, chemicals and resources focus, plus a life sciences practice. It is a broader incumbent that can compete on pharma/biotech facility mandates from large multinational sponsors.

Emerging players

• G-CON Manufacturing: G-CON manufactures prefabricated, modular cleanroom PODs used in biopharma manufacturing facilities. It addresses a related but distinct step in the facility build value chain (modular cleanroom supply) and competes with Biopharmax for cell/gene therapy and viral vector sponsors.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/biopharmax-group-ltd

Compliance10 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biopharmax Group